Virtual Ports Ltd. has obtained EU CE Mark for its EndoGrab device that reduces the number of incisions (or ports) needed to perform laparoscopic surgical procedures.
EndoGrab is an internally anchored, hands-free retracting device that eliminates the need for the hand-held retractor traditionally used during laparoscopic procedures, thereby reducing scarring and some of post-surgical complications associated with abdominal incisions.
In April 2007, less than a year after being founded, Virtual Ports obtained Food and Drug Administration (FDA) approval for the EndoGrab and another product, the EndoClear, for sale in the US. The company obtained approval through the abbreviated 510 (k) clearance, which does not require clinical trials. EndoGrab has already been used in 50 procedures, without any significant complications.
Virtual Ports CEO Udi Gordin said that the company was already in advanced talks with leading European distributors. The company handles sales in the US directly.
Virtual Ports has raised $400,000 to date from the Office of the Chief Scientist and Trendlines International Ltd.
Published by Globes [online], Israel business news - www.globes-online.com - on August 16, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009